AKUMS — Akums Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹148.05bn
- IN₹150.94bn
- IN₹41.78bn
Annual balance sheet for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 874 | 1,033 | 1,505 | 2,878 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 6,304 | 10,293 | 9,844 | 10,032 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 11,574 | 18,916 | 19,242 | 19,409 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 9,006 | 10,439 | 11,925 | 13,772 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 21,669 | 30,690 | 32,665 | 35,164 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 5,800 | 12,724 | 12,656 | 12,106 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 12,820 | 24,471 | 25,493 | 28,069 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 8,848 | 6,220 | 7,172 | 7,095 |
Total Liabilities & Shareholders' Equity | 21,669 | 30,690 | 32,665 | 35,164 |
Total Common Shares Outstanding |